drugset
drugset / Trial / NCT01844973

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

NCT01844973 ↗

Phase 1 Completed 30 enrolled Maruho North America Inc.
RandomizedParallel-groupDouble-blindBasic science

Summary

This study is to evaluate the pharmacokinetics and safety of M518101 in male and female plaque psoriasis patients.

Timeline

Start
2013-04
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator pefcalcitol Small molecule — —

Indications

psoriasis